| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
group | 0.100 | None | 0.800 | 10 | 0 | 1975 | 2017 | ||||||||
|
prolactin | 0.406 | 0.885 | 2.9E-07 |
|
group | 0.400 | None | 0.981 | 105 | 0 | 1981 | 2019 | ||||||||
|
PKHD1 ciliary IPT domain containing fibrocystin/polyductin | 0.576 | 0.654 | 1.2E-47 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1983 | 1983 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
group | 0.100 | None | 0.989 | 94 | 0 | 1985 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.400 | None | 0.911 | 141 | 4 | 1986 | 2020 | ||||||||
|
fucosyltransferase 4 | 0.505 | 0.731 | 7.7E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1987 | 1987 | ||||||||
|
growth hormone 2 | 0.769 | 0.500 | 2.5E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1987 | 1987 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1988 | 2016 | ||||||||
|
Fos proto-oncogene, AP-1 transcription factor subunit | 0.411 | 0.885 | 0.26 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | ||||||||
|
calcitonin related polypeptide alpha | 0.416 | 0.923 | 1.6E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.967 | 111 | 5 | 1990 | 2018 | ||||||||
|
growth hormone 1 | 0.373 | 0.923 | 3.0E-02 |
|
group | 0.100 | None | 0.948 | 97 | 0 | 1990 | 2019 | ||||||||
|
bromodomain containing 2 | 0.450 | 0.808 | 1.00 |
|
group | 0.100 | None | 0.929 | 14 | 0 | 1990 | 2017 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 1990 | 2019 | ||||||||
|
CEA cell adhesion molecule 4 | 0.716 | 0.423 | 6.1E-08 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 1990 | 1991 | ||||||||
|
complement C1q like 1 | 0.612 | 0.654 | 5.6E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | ||||||||
|
chromogranin A | 0.490 | 0.808 | 3.0E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | ||||||||
|
enolase 2 | 0.475 | 0.846 | 0.38 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | ||||||||
|
synemin | 0.575 | 0.731 | 3.0E-24 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | ||||||||
|
FYN proto-oncogene, Src family tyrosine kinase | 0.556 | 0.731 | 0.99 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | ||||||||
|
serine peptidase inhibitor Kazal type 1 | 0.492 | 0.808 | 0.31 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.400 | None | 0.944 | 84 | 2 | 1991 | 2020 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.100 | None | 0.938 | 16 | 0 | 1991 | 2012 | ||||||||
|
thyroid peroxidase | 0.455 | 0.846 | 1.8E-21 |
|
group | 0.050 | None | 1.000 | 4 | 0 | 1991 | 2020 | ||||||||
|
hypertrichosis 2 (generalized, congenital) | 0.392 | 0.808 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1991 | 2010 |